Your enquiry has been submitted
Anaerobic Basal Agar
Bacteroides#CC293D
Intended Use
Recommended for the growth of anaerobic microorganisms, particularly Bacteroides species and other fastidious anaerobes.
Composition**
| Ingredients | g/ L |
|---|---|
| Peptone | 16.000 |
| Yeast extract | 7.000 |
| Sodium chloride | 5.000 |
| Starch | 1.000 |
| Dextrose (Glucose) | 1.000 |
| Sodium pyruvate | 1.000 |
| Arginine | 1.000 |
| Sodium succinate | 0.500 |
| Sodium bicarbonate | 0.400 |
| L-Cysteine hydrochloride | 0.250 |
| Ferric pyrophosphate | 0.500 |
| Hemin | 0.005 |
| Vitamin K | 0.0005 |
| DL Dithiothreitol (DTT) | 0.250 |
| Agar | 12.000 |
Final pH ( at 25°C): 7.0±0.2
**Formula adjusted, standardized to suit performance parameters
Directions
Suspend 45.9 grams in 1000 ml purified/distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool to 45-50°C and aseptically add 5-10% sterile defibrinated horse blood. Mix well and pour into sterile Petri plates.
Principle And Interpretation
Bacteroides comprise a major portion of the human normal flora, predominating in the intestinal tract. These organisms are, like other anaerobes, generally opportunistic and can cause a variety of infections throughout the body. The most common infections include pleuropulmonary, intra-abdominal and infections of the female urogenital tract. Bacteroides make up about one-third of the total anaerobic isolates obtained from various infections. Anaerobic Basal media are very nutritious and hence recommended for fastidious anaerobes like Bacteroides species. Anaerobic organisms require reducing conditions and an absence of dissolved oxygen in the medium. Strict anaerobes obtain its energy and intermediates through oxidation utilizing hydrogen acceptors other than oxygen. Anaerobes are unable to grow if the medium contains dissolved oxygen. Pre-reducing the medium by boiling to drive off the oxygen can expel this. Also reducing agents such as thioglycollate or cysteine can be added to the medium (1).
Peptone and yeast extract provide nitrogen and carbon source, long chain amino acids, vitamins and other essential growth nutrients. Starch absorbs the toxic metabolites produced (2). Hemin and Vitamin K serves as essential growth factors for Bacteroides species (3). Sodium succinate helps to improve the growth of Bacteroides species (4). Sodium pyruvate serves as the energy source. It also mimics the role of catalase and degrades traces of hydrogen peroxide, which may be produced by the action of molecular oxygen on media components (5). Arginine and L-cysteine helps to revive and enhance the growth of certain anaerobes (6,7). It along with dithiothreitol also serves as reducing agent. Anaerobic basal agar can be made selective for gram-negative anaerobes by the addition of Non- spore Anaerobic Supplement (FD001) and G.N. Spore Anaerobic Supplement (FD002). The media can also be made selective for non- sporing anaerobes by the addition of Non spore Anaerobic Supplement (FD001). Anaerobic Basal Agar can be inoculated directly by surface streaking.
Type of specimen
Clinical samples - Throat swab, sputum, faeces
Specimen Collection and Handling
For clinical samples follow appropriate techniques for handling specimens as per established guidelines (8,9). After use, contaminated materials must be sterilized by autoclaving before discarding.
Warning and Precautions
In Vitro diagnostic use only. For professional use only. Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling clinical specimens. Safety guidelines may be referred in individual safety data sheets.
Limitations
- It is necessary to incubate inoculated media for a full 48 hours before examination and exposure of the inoculated culture to ambient air.
Performance and Evaluation
Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.
Quality Control
Appearance: Cream to yellow homogeneous free flowing powder
Gelling: Firm, comparable with 1.2% Agar gel
Colour and Clarity of prepared medium: Basal medium:Light amber clear to slightly opalescent gel. After addition of 5% v/v sterile defibrinated blood: Cherry red coloured opaque gel forms in Petri plates.
Reaction: Reaction of 4.6% w/v aqueous solution at 25°C. pH : 7.0±0.2
pH: 6.80-7.20
Cultural Response
Cultural characteristics observed with added 5% w/v sterile defibrinated blood, after an incubation at 35-37°C for 18-48 hours anaerobically.
| Organism | Growth |
|---|---|
| Peptostreptococcus anaerobius ATCC 27337 | luxuriant |
| Prevotella loescheii ATCC 15930 | luxuriant |
| Clostridium perfringens ATCC 13124 (00007*) | luxuriant |
| $Phocaeicola vulgatus ATCC 8482 | luxuriant |
| Bacteroides fragilis ATCC 23745 | luxuriant |
Key : (*) Corresponding WDCM numbers. $ Formerly known as Bacteroides vulgatus
Storage and Shelf Life
Store between 10-30°C in a tightly closed container and the prepared medium at 2-8°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition. Seal the container tightly after use. Product performance is best if used within stated expiry period.
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical sample must be decontaminated and disposed of in accordance with current laboratory techniques (8,9).
Reference
- Collee J. G., Fraser A. G. , Marmimon B. P., Simmons A., (Eds.), 1996, Mackie and McCartney, Practical Medical Microbiology, 14th Ed.,Churchill Livingstone.
- Ajello G.W. Geely JC, Hayes PS et al. J. Clin. Micro. 1984:20:55-8.
- Sperry JF. Wilkins TD. J. Bacteriol. 1976:127:780-784.
- Gibbons RJ and MacDonnald JB. J. Bact, 1960:80:164-170.
- Lev M. Keudell KC and Milford AF. J. bact, 1971:108:175-8.
- Neilson PA. J. Clin. Micr, 1983:17:276-279.
- Shanson DC and Singh J. J. Clin. Path. 1981:34:221-3.
- Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition.
- Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1.
| Product Name | Anaerobic Basal Agar |
|---|---|
| SKU | M1635 |
| Product Type | Regular |
| Physical Form | Powder |
| Origin | Animal |
| Packaging type | HDPE |
| References | 1. Collee J. G., Fraser A. G. , Marmimon B. P., Simmons A., (Eds.), 1996, Mackie and McCartney , Practical MedicalMicrobiology, 14th Ed.,Churchill Livingstone. |
| Customized Product Available | No |





